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Background. Maze procedure aims at restoring sinus rhythm (SR) and atrial contractility (AC). This study evaluated multiple
aspects of AC recovery and their relationship with SR regain after ablation.Methods. 122 mitral and fibrillating patients underwent
radiofrequency Maze. Rhythm check and echocardiographic control of biatrial contractility were performed at 3, 6, 12, and 24
months postoperatively. A multivariate Cox analysis of risk factors for absence of AC recuperation was applied. Results. At 2-
years follow-up, SR was achieved in 79% of patients. SR-AC coexistence increased from 76% until 98%, while biatrial contraction
detection augmented from 84 to 98% at late stage. Shorter preoperative arrhythmia duration was the only common predictor of SR-
AC restoring, while pulmonary artery pressure (PAP) negatively influenced AC recuperation. Early AC restoration favored future
freedom from arrhythmia recurrence. Minor LA dimensions correlated with improved future A/E value and vice versa. Right
atrial (RA) contractility restoring favored better left ventricular (LV) performance and volumes. Conclusions. SR and left AC are
two interrelated Maze objectives. Factors associated with arrhythmia “chronic state” (PAP and arrhythmia duration) are negative
predictors of procedural success. Our results suggest an association between postoperative LA dimensions and “kick” restoring and
an influence of RA contraction onto LV function.
1. Introduction
AF presents with different frequencies in patients affected
by structural heart diseases requiring surgery, showing a
peak incidence of up to 60–80% in mitral subjects [1]. It
causes an increased risk of systemic embolism, cardiac failure
development, and higher limitations due to dyspnea and
fatigue on exercise. Cox-Maze technique for surgical AF
treatment started being used in 1987 [2] and it has suffered
numerous modifications since then. Nowadays, most centers
have replaced the “cut and sew” technique by other methods
using several power sources to achieve the same target in a
much easier way [3]. One of the alternative energy sources
currently used is radiofrequency (RF) ablation which has
been demonstrated to be a simple, safe, and reproducible
procedure with an acceptable success rate in terms of SR
restoration [4].
The original Maze was designed with three specific goals
in mind: (1) the permanent AF ablation, (2) the restoration of
atrioventricular synchrony, and (3) the preservation of atrial
transport function [2]. If, by one side, the efficacy of the
procedure in reaching the first two goals is widely known
[5, 6], the restoration of the SR does not always accompany
the corresponding recuperation of atrial mechanical “kick”
[7, 8]. Atrial contraction is effective when A waves are found
in tricuspid and/or mitral transvalvular flow using Doppler
echocardiography [9], allowing the patient to fully profit
from hemodynamic and clinical advantages of an organized
atrial contraction. If the atrial transport function fails to
recover, benefits deriving from arrhythmia abolition might
only be marginal, since, by one side, blood stasis in the atria
persists, thus maintaining unchanged thromboembolic risk
and, by the other side, heart hemodynamic performance is
still impaired resulting from the loss of atrial contribution to
cardiac output [10].
Despite its relevant role for judging Maze comprehen-
sive success, biatrial contractility restoration and its clinical
importance have not been deeply investigated. In more
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Table 1: Patients characteristics.
𝑛 = 122
Sex (M : F) 59/63
Age (years) 62 ± 8.5
Chronic AF 79 (64.7%)
Paroxysmal AF 53 (35.3%)
AF duration (months) 28.3 (range 1–220)
LAD (mm) 56 ± 12
LAA (cm2) 34 ± 7
LVEDD (mm) 56 ± 8
LVESD (mm) 34 ± 9
PAP (mmHg) 33 ± 15
LVEF (%) 57 ± 9
Mitral stenosis 35 (39%)
Mitral regurgitation 87 (71%)
Mitral valve repair 76 (62%)
Mitral valve replacement 46 (38%)
AF, atrial fibrillation; LAD, left atrial diameter; LAA, left atrial area; LVEDD,
left ventricular end-diastolic diameter; LVESD, left ventricular end-systolic
diameter; LVEF, left ventricular ejection fraction; M : F, males : females.
detail, a parallel deep analysis and comparison of possible
determinants of both surgical ablation tied goals (AC and
SR achievement) is still lacking. In the present study, we
describe 2-year results of concomitant modified RF Maze in
a homogeneous population of mitral patients, focusing onto
common predictors of SR and AC restoring and their time-
course appearance and possible relationship with cardiac
chambers dimensions and function evolution.
2. Methods
2.1. Patients’ Characteristics. We analyzed a total of 122
consecutive patients with mitral valve disease scheduled
for cardiac surgery who underwent a modified RF Maze
procedure between January 2005 and June 2012 at our center
(Table 1). There were 59 males and 63 females, with a mean
age of 62 ± 8.5 years (range 30–82 years) at the time of
operation. 64.7% of patients had permanent or persistent AF
with a mean preoperative duration of 28.3 months (range
1–220 months); in the others our indication to perform
the concomitant RF was an at least double occurrence of
paroxysmal AF refractory to medical treatment (arrhythmia
definitions based on ACC/AHA Guidelines 2011) [11].
Mean preoperative LA dimensions were 56 ± 12mm and
34 ± 7 cm2. Mean basal PAP was 33 ± 15mmHg. Patients
experiencing mitral repair with residual regurgitation higher
than 1 degree (scale 1 to 4) were excluded from the study.
Preoperative clinical and echocardiographic variables are
showed in Table 1.
This study was approved by our institution’s ethical
committee/institutional review board.
2.2. Surgical Procedures. RF energy was used to create con-
tinuous endocardial and epicardial lesions mimicking most
of the left atrial incisions set as described in the Cox-Maze
RPV LPV
MV
Figure 1: Operation schema of left Maze. After epicardial isolation
of both pulmonary veins, we performed a double union line between
the left and right pulmonary islands and a lesion connecting the
right pulmonary one to the posterior annulus of the mitral valve at
P2 or P3 portion (according to circumflex artery anatomy). LPV =
left pulmonary veins. MV = mitral valve. RPV = right pulmonary
veins.
III procedure [12]. We did not perform any ablation line in
the right atrium (Figure 1). In all patients a bipolar device was
used (Cardioblate BP2 Irrigated RF Surgical Ablation System,
Medtronic Inc., Minneapolis, MN, USA).The tip of the probe
was irrigated with saline at room temperature at a flow rate of
4–6mL/min.
Cardiopulmonary bypass was used with standard aortic
cannulation, bicaval cannulation, and moderate hypother-
mia. After epicardial isolation of both pulmonary veins and
of the left atrial appendage performed before aortic cross-
clamping, some of the additional LA incisions sets currently
used in the “cut and sew” technique were replaced by RF
ablation lines, in particular represented by a double union
line between the left and right pulmonary islands and a
lesion connecting the right pulmonary one to the posterior
annulus of the mitral valve at P2 or P3 portion (according to
circumflex artery anatomy). In all patients the LA appendage
was internally or externally closed.
After completion of the RF ablation, mitral valve repair or
replacement was performed (Table 1).
2.3. Postoperative Management. Postoperative general care
was similar to routine cardiac surgical procedures. Modality
of amiodarone prophylaxis protocol treatment was the same
in all patients, represented by iv amiodarone 1200mg/24 h
in the first postoperative day, followed by 200mg per os
every 8 hours until hospital discharge and then 200mg
daily for six months. In case of amiodarone intolerance or
contraindications, propafenone was employed.
Patients showing SR or an ectopic atrial rhythm with
rate inferior to 70 bpm in the first 48–72 postoperative hours
were treated with temporary atrial pacing fixed at 80 bpm
with the aim of avoiding supraventricular ectopic beats
occurrence and consequently AF onset and of favoring atrial
electrical activity recovery. Postoperative atrial tachyarrhyth-
mias recurrences not responsive to medical treatment were
submitted to direct-current (DC) shock; in this case, a loading
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dose of amiodarone was administrated before and until 24
hours after DC shock and then interrupted.
2.4. Clinical Follow-Up. Early postoperative rhythms were
checked daily by standard 12-channel surface electrocardio-
gram. Follow-up 24-hour Holter monitoring was checked
postoperatively at 3, 6, 12, and 24 months after the interven-
tion.
2.5. Echocardiographic Follow-Up. Contemporary to clinical
follow-up, all patients were evaluated with 2-dimensional
transthoracic echocardiography by the same cardiologist at
3, 6, 12, and 24 months in order to specifically monitor
the evolution of cardiac chambers dimensions and systolic
performance and to record left and RA contractility presence.
In more detail, biatrial transport function was checked in
all patients, independently from the original (paroxysmal or
persistent) AF type.
All echocardiographic examinations were performed
with a Philips ultrasound system (iE33, Andover, MA, USA).
LA diameter was measured at the time of aortic valve closure
on the M-mode echocardiogram in the parasternal long-axis
view. End-diastolic and end-systolic internal LV diameters
were determined from the M-mode echocardiogram and
fractional shortening was obtained.
Systolic PAP was calculated by adding transtricuspid
pressure gradient tomean right atrial pressure estimated from
inferior vena cava diameter and motion during respiration
as follows: mean right atrial pressure was estimated to be
5mmHg if there was complete collapse of a normal inferior
vena cava during inspiration, 10mmHg if a normal inferior
vena cava collapse was >50%, 15mmHg if a dilated inferior
vena cava collapsed by >50% with inspiration, and 20mmHg
if there was no visible evidence of dilated inferior vena cava
collapse.
Transmitral flow velocity was measured with pulsed
Doppler echocardiography, with a sample volume positioned
at the level of the mitral tip in the apical four-chamber
view, and was recorded on a strip chart at a paper speed
of 100mm/s. Peak velocity and the time-velocity integral of
the early filling wave (E wave) and of the late filling wave
(A wave) were determined. A/E ratio, representing atrial
contribution to ventricular diastolic filling, was obtained.
Each measurement was obtained as an average of 6 to 8
consecutive beats. We considered that a peak A wave velocity
≥10 cm/s indicated echocardiographic evidence of effective
atrial contraction [9].
2.6. Statistical Analysis. Data were collected and managed
in Microsoft Excel 2003 and analyzed with SPSS 12.0 soft-
ware (SPSS, Inc., Chicago, IL, USA). Continuous variables
were presented as mean ± SD and categorical variables as
percentages or numbers. Seventeen variables were evaluated
univariately to identify predictors of arrhythmia recurrence
and of AC restoration. Univariate analysis was performed
for all relevant categorical variables by means of 𝜆2 analysis
and Student’s 𝑡-tests when indicated. A multivariate Cox
proportional hazard model (including factors positive at
univariate analysis) was used to determine the independent
predictors of AC recuperation and of AF reappearance. A
multiple events Cox model was applied too for taking into
account the chance of multiple arrhythmia and transport loss
recurrences.
Categoric and continuous variables associations were,
respectively, investigated with 𝜆2 test and Spearman rank
correlation coefficient.
McNemar test was employed for evaluating LA and RA
contractility concordance.
A value of 𝑝 less than 0.05 was considered statistically
significant.
3. Results
3.1. Early Postoperative Data and 2-Year Rhythm Follow-
Up. Mean aortic cross-clamp and cardiopulmonary bypass
time were, respectively, 95 ± 38 and 121 ± 43 minutes. In
all patients who underwent mitral valve repair, a residual
valvular regurgitation lower than 1 degree (scale 1 to 4) was
achieved.
One patient (0.8%) died in the Intensive Care Unit
for unresponsive cardiac failure. Postoperative complications
included major ischemic strokes (2/122, 1.6%) and reopera-
tion for bleeding (4/122, 3.2%) whose origin was not related
to Maze lesions.
79 patients (65%) were discharged from the hospital in
SR, 29 (24%) presented with stable AF, and 5 showed an atrial
flutterwhile 9 patients had an atrial ectopic rhythmwith heart
rate superior to 70 bpm.
2-year clinical follow-up was achieved in all patients.
There were 2 (1.6%) late deaths (1 progressive congestive heart
failure and 1 extra-cardiac cause). Stable SR was achieved in
96 patients (79%), while 18 (15%) experienced AF recurrence;
most of them (15/18, 83%) were persistent arrhythmias resis-
tant to pharmacological or electrical shock, and the others
had AF episodes responsive to medical treatment or DC
shock. No patients presented postincisional tachycardia. In
the whole study population, 7 patients (5.7%) underwent
permanent pacemaker implantation.
3.2. Contractility Restoration. At early follow-up (3 months),
only 76%of patients showing a stable SR presentedwith a cor-
responding efficacious left AC. Nevertheless, such percentage
of coexistence increased progressively, joining about 98% two
years after the operation (Figure 2).
LA contraction failed to be accompanied in every case
by a corresponding RA contraction, since, at 3 months of
follow-up, only in 84% of patients with an “A” wave both atria
efficaciously contracted (McNemarKappa coefficient equal to
0.68), while 2 years after the intervention the percentage of
bilateral “kick” coexistence reached 98% (McNemar Kappa
coefficient 0.87) (Figure 3).
In patients who remained in persistent SRwithout known
arrhythmia recurrence (nearly 74% of all population), left
A/E ratio slightly augmented until a mean value of 2.65 at 24
months of echocardiographic follow-up (Figure 4).
3.3. Risk Factors Analysis of Maze Failure. The univari-
ate analysis of the predictive factors of freedom from AF
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Figure 2: Sinus rhythm-left atrial contractility coexistence. The
percentage of sinus rhythm-left atrial transport function coexistence
increased progressively, joining about 98% two years after the
operation.
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Figure 3: Biatrial contractility coexistence. At 3 months follow up,
only in 84% of patients with an A wave both atria efficaciously
contracted (McNemarKappa coefficient equal to 0.68), while 2 years
after the intervention the percentage of bilateral “kick” coexistence
reached 98% (Mc Nemar Kappa coefficient 0.87).
recurrence at 2-years of follow-up is shown in Table 2 and
identifies as significant protective variables a preoperative
arrhythmia duration inferior to 36 months (meaning the
period of any AF type history: for longstanding one, it was
calculated from the beginning date, but for paroxysmal arrhy-
thmia from the date of the first episode recording), 3 and 6
months of leftAC restoration, and SRpresence at hospital dis-
charge. Such last feature failed to be confirmed atmultivariate
analysis (Table 2).
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Figure 4: Left A/E ratio trend. Left A/E ratio slightly augmented
until amean value of 2.65 at 24months of echocardiographic follow-
up. Vertical bars denote 95% confidence intervals.
Table 2: Univariate and multivariate analysis for freedom from AF
recurrence at 2-year follow-up.
Factors Univariate
𝑝 value
Multivariate analysis
HR 95% CI 𝑝 value
AF duration (>36 months) <0.0001 1.402 1.13–1.78 0.02
3-month left AC restoration <0.0001 1.238 1.07–1.52 0.03
6-month left AC restoration <0.0001 1.127 1.05–1.48 0.04
AF at discharge 0.003 0.841 0.49–1.23 0.21
Cross-clamp time 0.13
Age 0.23
Rheumatic disease 0.13
PAP 0.09
Sex 0.25
Permanent/persistent AF 0.18
Postoperative bleeding 0.26
CPB time 0.24
LAD (mm) 0.17
LAA (cm2) 0.12
LVESD (mm) 0.28
LVEDD (mm) 0.25
LVEF (%) 0.31
Not all factors were entered into multivariate model.
AF, atrial fibrillation; CI, confidence interval; CPB, cardiopulmonary bypass;
HR, hazard ratio; LAA, left atrial area; LAD, left atrial diameter; LVEDD, left
ventricular end-diastolic diameter; LVEF, left ventricular ejection fraction;
LVESD, left ventricular end-systolic diameter; PAP, pulmonary artery pres-
sure.
Due to uniformity of antiarrhythmic prophylaxis and
treatment in case of arrhythmia recurrence the item “amio-
darone use” was not included in the statistical analysis of risk
factors of Maze failure.
In order to better evaluate the theoretical possibility of
several AF recurrences, a multiple events Cox model was
applied, again revealing the protective role played by a shorter
preoperative arrhythmia duration and by early AC regain.
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Table 3: Univariate and multivariate analysis for absence of LA
contractility recovery at 3 months of follow-up.
Factors Univariate
𝑝 value
Multivariate analysis
HR 95% CI 𝑝 value
PAP <0.0001 1.05 1.01–1.11 0.02
LAA (cm2) 0.002 1.06 1.01–1.14 0.06
Duration of AF 0.003 1.014 1–1.03 0.06
Age 0.23
Rheumatic disease 0.12
Sex 0.14
Permanent/persistent AF 0.18
Postoperative bleeding 0.47
CPB time 0.31
Cross-clamp time 0.19
AF at discharge 0.17
LAD (mm) 0.08
LVESD (mm) 0.28
LVEDD (mm) 0.73
LVEF (%) 0.58
Not all factors were entered into multivariate model.
AF, atrial fibrillation; CI, confidence interval; CPB, cardiopulmonary bypass;
HR, hazard ratio; LAA, left atrial area; LAD, left atrial diameter; LVEDD, left
ventricular end-diastolic diameter; LVEF, left ventricular ejection fraction;
LVESD, left ventricular end-systolic diameter; PAP, pulmonary artery pres-
sure.
3.4. Predictive Factors of LA Contractility Restoration. The
same features used for uni- and multivariate analysis for
freedom from AF recurrence (with the obvious replacement
of 3 and 6 months of left AC by 3 and 6 months of SR
presence for late AC regain evaluation) were entered into
the statistical model in order to evaluate possible predictive
factors for absence of left AC recovery. At multivariate
analysis, significant predictors for absence of LA transport
function restoring were preoperative arrhythmia duration for
6–12 and 24 months of follow-up (𝑝 value 0.005, 0.05, and
0.017, resp.) and basal PAP for 3 and 6 months of contractility
(𝑝 value 0.02 and 0.03, resp.). 3- and 24-month results are
shown in Tables 3 and 4. No other common clinical or
operative features were highlighted in patients presenting SR
without corresponding AC at different follow-up checks.
Again, a multiple events Cox model was applied, con-
firming the unfavorable role played by longer AF duration
(𝑝 = 0.005) and by higher PAP (𝑝 = 0.029) (Table 5).
3.5. Contractility and Echocardiographic Measurements.
Some statistically significant associations were retrieved
between cardiac chambers dimensions and function and bia-
trial A/E ratios (considered as markers of contractility pre-
sence) evaluated at different follow-up times; in more detail
(Table 6),
(i) minor LA dimensions were related with improved
future A/E value and consequently with more pro-
nounced LA contractility;
Table 4: Univariate and multivariate analysis for absence of LA
contractility recovery at 24 months of follow-up.
Factors Univariate
𝑝 value
Multivariate analysis
HR 95% CI 𝑝 value
Duration of AF <0.0002 1.034 1.006–1.063 0.017
3-month SR presence 0.07
6-month SR presence 0.08
LAA (cm2) 0.09
PAP 0.08
Age 0.26
Rheumatic disease 0.31
Sex 0.18
Permanent/persistent AF 0.12
Postoperative bleeding 0.59
CPB time 0.64
Cross-clamp time 0.33
AF at discharge 0.24
LAD (mm) 0.12
LVESD (mm) 0.35
LVEDD (mm) 0.78
LVEF (%) 0.49
Not all factors were entered into multivariate model.
AF, atrial fibrillation; CI, confidence interval; CPB, cardiopulmonary bypass;
HR, hazard ratio; LAA, left atrial area; LAD, left atrial diameter; LVEDD, left
ventricular end-diastolic diameter; LVEF, left ventricular ejection fraction;
LVESD, left ventricular end-systolic diameter; PAP, pulmonary artery pres-
sure.
Table 5: Multiple events Cox model for absence of LA contractility
recovery.
Factors HR 95% CI 𝑝 value
Duration of AF (>36 months) 1.14 1.07–1.22 0.005
PAP 1.12 1.04–1.21 0.029
AC, atrial contractility; AF, atrial fibrillation; CI, confidence interval; HR,
hazard ratio; PAP, pulmonary artery pressure.
(ii) 3-month augmented left A/E favored greater im-
provement of LA diameter evaluated 1 and 2 years
after surgery;
(iii) 3 and 24 months of better RA contractility corre-
sponded to minor contemporary decrease of LVEF
with respect to basal values;
(iv) 12-month greater right A/E ratio was associated with
decreased 24-month LV volumes and better LVEF.
4. Discussion
The association between AF and mitral valve disease is
present in almost 60% of cases needing surgical correction.
For more than 20 years, Cox-Maze procedure has been
the gold standard for treating AF surgically [13]; despite its
high success rate, it entails long surgery times and signifi-
cant bleeding risks [14]. That is the reason why alternative
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Table 6: Contractility and echocardiographic measurements
(Spearman rank correlation).
Factors 𝑝 value
3 months of LAD–6 months of left A/E 0.035
3 months of LAA–6 months of left A/E 0.023
3 months of LAD–12 months of left A/E 0.033
6 months of LAA–12 months of left A/E 0.033
6 months of LAA–24 months of left A/E 0.023
3 months of left A/E–12 months of LAD 0.009
3 months of left A/E–24 months of LAD 0.029
3 months of right A/E–3 months of delta LVEF 0.035
24 months of right A/E–24 months of delta LVEF 0.044
12 months of right A/E–24 months of LVEDD 0.033
12 months of right A/E–24 months of LVEF 0.022
LAD, left atrial diameter; LAA, left atrial area; LVEDD, left ventricular end-
diastolic diameter; LVEF, left ventricular ejection fraction.
Delta LVEF means the difference between follow-up time LVEF and basal
LVEF.
energy sources and simplifications of ablation sets have been
progressively developed, including irrigated RF. Such device
achieves an acceptable (although inferior to the surgical
Maze) degree of SR conversion at mid-long-term follow-up,
equal to 45–95% [15–17].
If arrhythmia abolition has represented the most impor-
tant goal of the procedure, it was even specifically conceived
for allowing the entire atrial myocardium to be activated
preserving postoperative atrial transport function [10]. The
importance of AC is double, since, firstly, it may contribute
to an increase in stroke volume, particularly in case of fast
heart rates [18], and second, it is reasonable to think that the
absence of an efficacious mechanical atrial action recovery
even if associated with SR detection could favor intra-atrial
thrombi formation and consequent thromboembolic sys-
temic phenomena [19], thus making the decision to interrupt
anticoagulant treatment unsafe.
Based upon such considerations, we decided to focus
our attention onto biatrial transport function behavior in a
relatively homogeneous sample of patients affected by mitral
valve disease and concomitant AF in whom RF modified
left Maze procedure obtained 2-year arrhythmia abolition in
about 80% of cases, in agreement with what is reported in
medical literature.
Previous studies retrieved that restoration of both SR and
atrial contraction varies from 21% to 95%, depending on AF
etiology [20–25]. In more detail, in case of exclusively LA
Maze ablation, it has been proved that, despite successful SR
restoration, the progressive loss of LA function as well as LV
diastolic function is more prominent in patients affected by
rheumatic disease with respect to those with degenerative
prolapse [26].
In our trial, AC restoring was a dynamic and raising
process, a finding that perhaps translates into the practical
advice of persisting in serially controlling by echocardiogra-
phy also patients that early experience SR reestablishment few
months after the procedure, because in about three-quarters
of cases LA is still “stunned.” This consideration may assume
a great empirical role, since it discourages from interrupting
anticoagulant and antiarrhythmic treatment too early, even in
presence of detected stable SR and low CHADS2 score.
Another element that could support this prudent attitude
is the evidence of progressive increase of atrial contribution
entity. A/E ratio time-course after Maze is a discussed
question, as some authors [27] describe a decreasing trend
but others [10] a fluctuant tendency more in line with our
findings. On the contrary, Yuda and colleagues [28] demon-
strated that once AC was resumed, its degree did not change
during follow-up: the difference with respect to our results
may lie in the major prevalence in their sample of mitral
valve replacement (prosthesis could modify modality of LA
transport function) and of basal LV dysfunction associated
with a more aggressive lesions set performed with mixed
cut and sew technique and cryoenergy. A recent report from
Sayed et al. [29] highlighted the fact that the “left side only”
ablation procedure, when compared to biatrial one, allowed
better 6-month A/E ratio but with a mean value largely lower
(0.52) than the one emerging from our trial. Nevertheless,
again, enrolled patientswere all affected by rheumatic disease,
thus perhaps explaining worse postoperative atrial function.
Starting from the assumption that SR and AC recovery
represent two inseparable arms of the same question, we
tried to deeply examine possible predictors of restoration
and maintenance of atrial transport function at different
intervals, with the objective of screening patients who could
fully benefit from the procedure. Moreover, we applied a
supplementary statistical tool addressed at also evaluating
the intrinsic arrhythmia nature consisting in its chance of
several recurrent episodes. In fact, it is well known that
many subjects experience repeated heart rhythm changes
(and consequently disappearance of atrial “kick”) above all
in the first postoperative months, probably due to recovery
process, to postprocedural inflammation status, or to altered
neurohumoral mechanisms [30].
The only shared negative predictive factor for both SR
and left AC restoring highlighted by our analysis was preop-
erative AF duration, with a cut-off identified at 36 months.
If the role of longstanding arrhythmia largely emerged in
medical literature [31, 32], other issues were unexpectedly
retrieved: inmore detail, early atrial transport function regain
was found to strictly correlate with future stable freedom
from arrhythmia recurrence, while basal PAP influenced the
possibility of left AC recuperation in the early postoperative
phases and thus the symmetrical Maze goal of SR achieve-
ment. Concerning the former association, to the best of
our knowledge, this represents the first report in medical
literature, but, interestingly, the reverse interrelation failed
to be retrieved. We may speculate that AC is a secondary
phenomenonwhich follows SR recovery (and not in all cases)
and which is consequently something of more definitive
favoring perpetuation of SR, while early SR appearance could
be a temporary event not necessarily implying rhythm and
atrial transport function stability.
The discouraging role played by basal PAP onto future
atrial transport function recuperation was previously
reported only by Reyes et al. [33], but without statistical
significance. Its real implication needs surely further analysis
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but may perhaps reflect the fact that fixed and longstanding
mitral pathology associated with chronic AF which have
already caused progressive augmentation of pulmonary
pressures with effects onto pulmonary circulation represent
a more serious and advanced disease stage implying more
possibilities of Maze failure. A deeper investigation of
which type of pulmonary hypertension is involved (pre- or
postcapillary, in order to understand if its adverse role is
more due to a pulmonary or cardiac component) is required
but perhaps arises the doubt whether a more comprehensive
patient’s evaluation including right heart performance
should be performed.
Medical literature extensively addressed the problem of
identifying predictors able to discourage the surgeon to per-
form ablation, including old age, larger LA diameter, lower
amplitude of p-wave, having a rheumaticmitral valve disease,
permanent AF, and lesion sets of Maze procedures [32, 34].
In case of analysis specifically focused onto restoration of
atrial contraction, AF duration, LA diameter, an history
of hypertension, rheumatic disease, and the presence of
prosthetic valve failure arose as significant negative predictors
[25, 26, 35]. In our opinion, all these features reflect the
negative influence played by arrhythmia “chronic state” onto
Maze success; the same conclusion can be suggested by
our data too, since PAP and longer preoperative arrhythmia
duration are intimately linked with the idea of a longstanding
phenomenon. Based upon such concept, we can perhaps
draw the suggestion of carefully screening patients poten-
tially candidates to surgical ablation, being aware that those
presenting “ancient” arrhythmia with augmented PAP will
unlikely benefit from the procedure.
Nevertheless, in our analysis, LA dimensions did not
represent a negative predictor of SR-AC restoring; however,
such absence of relationship is partially mitigated by the
finding of a bidirectional association between LA size and
chance of future AC recovery or, at the opposite, between
early atrial “kick” recuperation andmoremarked future atrial
diameter and area decrease. To the best of our knowledge,
this is the first demonstration of a strength link between these
two elements which are logically and theoretically related but
whose modality of respective behavior was not completely
clear.
Moreover, we found that the atria seem to differently
regain contraction after Maze. Available data addressing the
question show various rates of RA function recovery [10,
33]. Although it is not directly touched, we can imagine
that RA is somehow influenced by the ablation procedure
itself. Such subject may represent an interesting matter also
considering that, in our study, RA transport function recu-
peration appears to favor better contemporary and future LV
contractile performance anddecreased volumes. Even if these
findings have not been found at all follow-up intervals, they
may represent an intriguing hypothesis of a supplementary
interrelation between right and left cardiac sides leading to
the suggestion of reconsidering RA role.
An important study limitation is represented by the
limited sample size which does not allow drawing definitive
conclusions; we believe that our preliminary results should be
confirmed in larger trials including “more ancient”mitral and
fibrillating patients, in order to better describe the negative
influence of longstanding arrhythmia onto Maze objectives.
5. Conclusions
We serially assessed biatrial function after RF Maze proce-
dure in patients affected by mitral valve disease.
In the early postoperative phases, a regular rhythm with
P-waves was accompanied by a coexisting atrial transport
function only in three quarters of cases, but concordance
joined about 100% at two years of follow-up. Once LA
contraction was resumed, its degree augmented progressively
and was associated with a corresponding RA transport
function in an increasing percentage of cases at late follow-up.
A strict interaction was detected between LA chamber
postoperative evolution and LA contractility recovery, as a
decrease of LA size favored atrial “kick” reappearance and
vice versa.
SR and AC appear to be two intimately linked objectives
of the Maze procedure, since early atrial transport function
recuperation favors future stable freedom from arrhythmia
recurrence.
Our study highlighted the deleterious influence of
arrhythmia “chronic state” onto procedural success and the
importance of the cardiac right side, an entity somehow
overlooked: even if these data need further investigation
in order to elucidate a possible clinical implication too, we
retrieved that, first, preoperative arrhythmia duration and,
more interesting, pulmonary hypertension (an element that
could be associated with a latent right ventricular dysfunc-
tion) play a role in predicting Maze failure in terms of SR-AC
restoring and, second, RA contractility has an influence on
LV contractile performance recovery and volumes decrease.
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